Table 2.

Immunoexpression levels (pg/mL) of MFN1 and FIS1 proteins in patients and controls.

Groups	MFN1	FIS1
Lung cancer patients/NSCLC patients (n = 47)	19.8 pg/mL ± 31.5 (IQR: 8.500–21.250)	0.5 pg/mL ± 0.5 (IQR: 0.253–0.512)
Control group (n = 21)	10.2 pg/mL ± 6.9 (IQR: 6.400–9.925)	2.2 pg/mL ± 4.4 (IQR: 0.436–1.699)
The significance level	p = 0.007	p = 0.00006